Profil
Charles Hugh-Jones is the Global Chief Medical Officer at Fresenius Medical Care AG, starting in 2026.
Formerly, Dr. Hugh-Jones was Chief Executive Officer at Volastra Therapeutics, Inc., Chief Medical Officer at Allergan UC from 2018 to 2020, and worked at Addleshaw Booth & Co. from 2004 to 2007.
Aktive Positionen von Charles Hugh-Jones
| Unternehmen | Position | Beginn |
|---|---|---|
| FRESENIUS MEDICAL CARE AG | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2026 |
Ehemalige bekannte Positionen von Charles Hugh-Jones
| Unternehmen | Position | Ende |
|---|---|---|
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics | Vorstandsvorsitzender | 27.05.2025 |
| ALLERGAN PLC | Technik-/Wissenschafts-/F&E-Leiter | 08.05.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Fresenius Medical Care AG
Fresenius Medical Care AG Medical/Nursing ServicesHealth Services Manufactures and supplies renal and dialysis products | Health Services |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics | Health Technology |
















